Chongqing Pharscin Pharmaceutical Co Ltd (002907) — Cash Flow Quality Index
Chongqing Pharscin Pharmaceutical Co Ltd (002907) has a Cash Flow Quality Index of 0.05x as of September 2025. Operating cash flow of CN¥833.94K is below net income of CN¥18.51 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore Chongqing Pharscin Pharmaceutical Co Ltd balance sheet assets for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Chongqing Pharscin Pharmaceutical Co Ltd Cash Flow Quality Index (2013–2024)
Historical Cash Flow Quality Index for Chongqing Pharscin Pharmaceutical Co Ltd across 12 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 002907 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Chongqing Pharscin Pharmaceutical Co Ltd (2013–2024)
Year-by-year earnings quality comparison for Chongqing Pharscin Pharmaceutical Co Ltd. For live market cap and the full company financial profile, see 002907 market cap overview.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 2.11x | CN¥161.77 Million | CN¥76.73 Million | ▼ -68.6% |
| 2023 | 6.71x | CN¥219.34 Million | CN¥32.70 Million | ▲ +4959.9% |
| 2022 | 0.13x | CN¥13.04 Million | CN¥98.40 Million | ▼ -85.3% |
| 2021 | 0.90x | CN¥82.85 Million | CN¥91.78 Million | ▼ -5.3% |
| 2020 | 0.95x | CN¥113.64 Million | CN¥119.19 Million | ▲ +145.5% |
| 2019 | 0.39x | CN¥65.92 Million | CN¥169.75 Million | ▲ +67.8% |
| 2018 | 0.23x | CN¥31.80 Million | CN¥137.37 Million | ▼ -68.1% |
| 2017 | 0.73x | CN¥81.34 Million | CN¥111.99 Million | ▲ +20.4% |
| 2016 | 0.60x | CN¥57.73 Million | CN¥95.71 Million | ▼ -33.7% |
| 2015 | 0.91x | CN¥66.10 Million | CN¥72.69 Million | ▲ +166.7% |
| 2014 | 0.34x | CN¥20.22 Million | CN¥59.30 Million | ▼ -79.1% |
| 2013 | 1.64x | CN¥47.34 Million | CN¥28.95 Million | — |